Financial results - DERMATOMED S.R.L.

Financial Summary - Dermatomed S.r.l.
Unique identification code: 9088309
Registration number: J35/1694/1996
Nace: 8622
Sales - Ron
51.234
Net Profit - Ron
2.959
Employee
5
The most important financial indicators for the company Dermatomed S.r.l. - Unique Identification Number 9088309: sales in 2023 was 51.234 euro, registering a net profit of 2.959 euro and having an average number of 5 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Dermatomed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 60.487 40.034 26.350 28.059 26.064 28.635 33.793 50.272 53.752 51.234
Total Income - EUR 60.513 40.113 26.388 28.080 26.072 29.163 33.795 50.274 53.755 51.670
Total Expenses - EUR 38.431 32.302 32.837 37.490 34.346 39.484 38.324 38.508 41.688 48.267
Gross Profit/Loss - EUR 22.083 7.811 -6.449 -9.410 -8.274 -10.321 -4.529 11.766 12.067 3.403
Net Profit/Loss - EUR 20.267 6.608 -6.713 -9.691 -8.535 -10.613 -4.844 11.274 11.610 2.959
Employees 6 5 5 5 5 5 5 5 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -4.4%, from 53.752 euro in the year 2022, to 51.234 euro in 2023. The Net Profit decreased by -8.616 euro, from 11.610 euro in 2022, to 2.959 in the last year.

Check the financial reports for the company - Dermatomed S.r.l.

Rating financiar

Financial Rating -
Dermatomed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Dermatomed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dermatomed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Dermatomed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dermatomed S.r.l. - CUI 9088309

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 7.855 11.425 8.837 7.915 7.756 7.261 6.862 8.943 9.831 9.091
Current Assets 78.271 79.207 74.004 63.917 59.746 44.578 41.757 46.043 57.044 62.079
Inventories 0 0 0 104 102 178 98 96 96 96
Receivables 49.707 48.443 48.440 46.740 46.871 32.631 24.139 24.762 23.816 26.103
Cash 28.564 30.763 25.564 17.073 12.773 11.769 17.520 21.185 33.132 35.880
Shareholders Funds 74.628 81.859 74.311 63.363 53.665 42.013 36.372 46.840 58.595 61.377
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 11.562 8.869 8.612 8.481 14.010 10.320 12.456 8.426 8.859 10.306
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 62.079 euro in 2023 which includes Inventories of 96 euro, Receivables of 26.103 euro and cash availability of 35.880 euro.
The company's Equity was valued at 61.377 euro, while total Liabilities amounted to 10.306 euro. Equity increased by 2.959 euro, from 58.595 euro in 2022, to 61.377 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Dermatomed S.r.l.

Comments - Dermatomed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.